1887
  1. Home
  2. Publications
  3. Journal of General Virology
  4. Volume 88, Issue 6
  5. Article

oa Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein

PDF
1.80 MB
HTML
93.46 Kb
  • Received:
  • Accepted:
  • Cover date:
Preview this:
Free Preview thumbnail Magnify
Zoom in
Zoomout

Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein, Page 1 of 1

| /docserver/preview/fulltext/jgv/88/6/1656-1.gif

  • Vaccinia virus (VACV) encodes many immunomodulatory proteins, including inhibitors of apoptosis and modulators of innate immune signalling. VACV protein N1 is an intracellular homodimer that contributes to virus virulence and was reported to inhibit nuclear factor (NF)-B signalling. However, analysis of NF-B signalling in cells infected with recombinant viruses with or without the gene showed no difference in NF-B-dependent gene expression. Given that N1 promotes virus virulence, other possible functions of N1 were investigated and this revealed that N1 is an inhibitor of apoptosis in cells transfected with the gene and in the context of VACV infection. In support of this finding virally expressed N1 co-precipitated with endogenous pro-apoptotic Bcl-2 proteins Bid, Bad and Bax as well as with Bad and Bax expressed by transfection. In addition, the crystal structure of N1 was solved to 2.9 Å resolution (0.29 nm). Remarkably, although N1 shows no sequence similarity to cellular proteins, its three-dimensional structure closely resembles Bcl-x and other members of the Bcl-2 protein family. The structure also reveals that N1 has a constitutively open surface groove similar to the grooves of other anti-apoptotic Bcl-2 proteins, which bind the BH3 motifs of pro-apoptotic Bcl-2 family members. Molecular modelling of BH3 peptides into the N1 surface groove, together with analysis of their physico-chemical properties, suggests a mechanism for the specificity of peptide recognition. This study illustrates the importance of the evolutionary conservation of structure, rather than sequence, in protein function and reveals a novel anti-apoptotic protein from orthopoxviruses.

  • Published online ahead of print on 22 March 2007 as DOI 10.1099/vir.0.82772-0.

  • †These authors contributed equally to this work.

  • ‡ Crystallography Group, ITQB-Instituto de Tecnologia Química e Biológica, Av. República, EAN, 2784-505 Oeiras, Portugal.

  • § Department of Respiratory Medicine, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.

  • Atomic coordinates and structural factors have been deposited at the Protein Data Bank under the accession codes 2uxe and r2uxesf.

SGM | Published by the Microbiology Society

  • Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F. & Rock, D. L. ( 2000; ). The genome of fowlpox virus. J Virol 74, 3815–3831.[CrossRef]
    [Google Scholar]
  • Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Rock, D. L. & Kutish, G. F. ( 2001; ). The genome of turkey herpesvirus. J Virol 75, 971–978.[CrossRef]
    [Google Scholar]
  • Aoyagi, M., Zhai, D., Jin, C., Aleshin, A. E., Stec, B., Reed, J. C. & Liddington, R. C. ( 2007; ). Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 16, 118–124.
     [Google Scholar]
  • Bartlett, N., Symons, J. A., Tscharke, D. C. & Smith, G. L. ( 2002; ). The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol 83, 1965–1976.
     [Google Scholar]
  • Bassik, M. C., Scorrano, L., Oakes, S. A., Pozzan, T. & Korsmeyer, S. J. ( 2004; ). Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. EMBO J 23, 1207–1216.[CrossRef]
    [Google Scholar]
  • Brown, J., Walter, T. S., Carter, L., Abrescia, N. G. A., Aricescu, A. R., Batuwangala, T. D., Bird, L. E., Brown, N., Chamberlain, P. P. & other authors ( 2003; ). A procedure for setting up high-throughput nanolitre crystallization experiments. II. Crystallization results. J Appl Crystallogr 36, 315–318.[CrossRef]
    [Google Scholar]
  • Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M. & other authors ( 1998; ). Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54, 905–921.
     [Google Scholar]
  • Chou, J. J., Li, H., Salvesen, G. S., Yuan, J. & Wagner, G. ( 1999; ). Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615–624.[CrossRef]
    [Google Scholar]
  • Cooray, S., Best, J. M. & Jin, L. ( 2003; ). Time-course induction of apoptosis by wild-type and attenuated strains of rubella virus. J Gen Virol 84, 1275–1279.[CrossRef]
    [Google Scholar]
  • Cory, S., Huang, D. C. & Adams, J. M. ( 2003; ). The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22, 8590–8607.[CrossRef]
    [Google Scholar]
  • Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G. & Franceschi, C. ( 1993; ). A new method for cytofluorometric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6'-tetrachloro-1,1',3,3′-tetraethylbenzimidazolcarbocyanineiodide (JC-1). Biochem Biophys Res Commun 197, 40–45.[CrossRef]
    [Google Scholar]
  • Davis, I. W., Murray, L. W., Richardson, J. S. & Richardson, D. C. ( 2004; ). MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res 32, W615–W619.[CrossRef]
    [Google Scholar]
  • Day, C. L., Chen, L., Richardson, S. J., Harrison, P. J., Huang, D. C. & Hinds, M. G. ( 2005; ). Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem 280, 4738–4744.[CrossRef]
    [Google Scholar]
  • DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A. & Marshall, W. L. ( 2004; ). Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by toll-like receptors. J Biol Chem 279, 36570–36578.[CrossRef]
    [Google Scholar]
  • Emsley, P. & Cowtan, K. ( 2004; ). Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126–2132.[CrossRef]
    [Google Scholar]
  • Fischer, S. F., Ludwig, H., Holzapfel, J., Kvansakul, M., Chen, L., Huang, D. C., Sutter, G., Knese, M. & Hacker, G. ( 2006; ). Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ 13, 109–118.[CrossRef]
    [Google Scholar]
  • Foyouzi-Youssefi, R., Arnaudeau, S., Borner, C., Kelley, W. L., Tschopp, J., Lew, D. P., Demaurex, N. & Krause, K. H. ( 2000; ). Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci U S A 97, 5723–5728.[CrossRef]
    [Google Scholar]
  • Haga, I. R. & Bowie, A. G. ( 2005; ). Evasion of innate immunity by vaccinia virus. Parasitology 130, (Suppl.), S11–S25.[CrossRef]
    [Google Scholar]
  • Hickish, T., Robertson, D., Clarke, P., Hill, M., di Stefano, F., Clarke, C. & Cunningham, D. ( 1994; ). Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res 54, 2808–2811.
     [Google Scholar]
  • Hinds, M. G., Lackmann, M., Skea, G. L., Harrison, P. J., Huang, D. C. & Day, C. L. ( 2003; ). The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J 22, 1497–1507.[CrossRef]
    [Google Scholar]
  • Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W. & Olejniczak, E. T. ( 2002; ). Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci U S A 99, 3428–3433.[CrossRef]
    [Google Scholar]
  • Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W. & Olejniczak, E. T. ( 2003; ). Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J Mol Biol 332, 1123–1130.[CrossRef]
    [Google Scholar]
  • Kotwal, G. J., Hugin, A. W. & Moss, B. ( 1989; ). Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 171, 579–587.[CrossRef]
    [Google Scholar]
  • Kyte, J. & Doolittle, R. F. ( 1982; ). A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105–132.[CrossRef]
    [Google Scholar]
  • Liu, X., Dai, S., Zhu, Y., Marrack, P. & Kappler, J. W. ( 2003; ). The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19, 341–352.[CrossRef]
    [Google Scholar]
  • Loh, J., Huang, Q., Petros, A. M., Nettesheim, D., van Dyk, L. F., Labrada, L., Speck, S. H., Levine, B., Olejniczak, E. T. & Virgin, H. W. ( 2005; ). A surface groove essential for viral bcl-2 function during chronic infection in vivo. PLoS Pathog 1, e10 [CrossRef]
    [Google Scholar]
  • Martinou, J. C. & Green, D. R. ( 2001; ). Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2, 63–67.
     [Google Scholar]
  • Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B. & other authors ( 1996; ). X-ray and NMR structure of Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341.[CrossRef]
    [Google Scholar]
  • Neilan, J. G., Lu, Z., Afonso, C. L., Kutish, G. F., Sussman, M. D. & Rock, D. L. ( 1993; ). An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol 67, 4391–4394.
     [Google Scholar]
  • O'Neill, J. W., Manion, M. K., Maguire, B. & Hockenbery, D. M. ( 2006; ). BCL-XL dimerization by three-dimensional domain swapping. J Mol Biol 356, 367–381.[CrossRef]
    [Google Scholar]
  • Otwinowski, T. C. & Minor, W. ( 1997; ). Processing of X-ray defraction data collected in oscillation mode. Methods Enzymol 276, 307–326.
     [Google Scholar]
  • Petros, A. M., Nettesheim, D. G., Wang, Y., Olejniczak, E. T., Meadows, R. P., Mack, J., Swift, K., Matayoshi, E. D., Zhang, H. & other authors ( 2000; ). Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci 9, 2528–2534.[CrossRef]
    [Google Scholar]
  • Petros, A. M., Medek, A., Nettesheim, D. G., Kim, D. H., Yoon, H. S., Swift, K., Matayoshi, E. D., Oltersdorf, T. & Fesik, S. W. ( 2001; ). Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A 98, 3012–3017.[CrossRef]
    [Google Scholar]
  • Petros, A. M., Olejniczak, E. T. & Fesik, S. W. ( 2004; ). Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644, 83–94.[CrossRef]
    [Google Scholar]
  • Polster, B. M., Pevsner, J. & Hardwick, J. M. ( 2004; ). Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim Biophys Acta 1644, 211–227.[CrossRef]
    [Google Scholar]
  • Postigo, A., Cross, J. R., Downward, J. & Way, M. ( 2006; ). Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ 13, 1651–1662.[CrossRef]
    [Google Scholar]
  • Roulston, A., Marcellus, R. C. & Branton, P. E. ( 1999; ). Viruses and apoptosis. Annu Rev Microbiol 53, 577–628.[CrossRef]
    [Google Scholar]
  • Sarid, R., Sato, T., Bohenzky, R. A., Russo, J. J. & Chang, Y. ( 1997; ). Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 3, 293–298.[CrossRef]
    [Google Scholar]
  • Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S. & other authors ( 1997; ). Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983–986.[CrossRef]
    [Google Scholar]
  • Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A. & McFadden, G. ( 2003; ). Poxviruses and immune evasion. Annu Rev Immunol 21, 377–423.[CrossRef]
    [Google Scholar]
  • Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. ( 2005; ). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122, 669–682.[CrossRef]
    [Google Scholar]
  • Stuart, D. I., Levine, M., Muirhead, H. & Stammers, D. K. ( 1979; ). Crystal structure of cat muscle pyruvate kinase at a resolution of 2. Å. J Mol Biol 134, 109–142.[CrossRef]
    [Google Scholar]
  • Suzuki, M., Youle, R. J. & Tjandra, N. ( 2000; ). Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103, 645–654.[CrossRef]
    [Google Scholar]
  • Taylor, J. M. & Barry, M. ( 2006; ). Near death experiences: poxvirus regulation of apoptotic death. Virology 344, 139–150.[CrossRef]
    [Google Scholar]
  • Terwilliger, T. C. ( 2000; ). Maximum-likelihood density modification. Acta Crystallogr D Biol Crystallogr 56, 965–972.[CrossRef]
    [Google Scholar]
  • Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Kutish, G. F. & Rock, D. L. ( 2004; ). The genome of canarypox virus. J Virol 78, 353–366.[CrossRef]
    [Google Scholar]
  • Virgin, H. W., IV, Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J. & Speck, S. H. ( 1997; ). Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71, 5894–5904.
     [Google Scholar]
  • Walter, T. S., Diprose, J., Brown, J., Pickford, M., Owens, R. J., Stuart, D. I. & Harlos, K. ( 2003; ). A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation. J Appl Crystallogr 36, 308–314.[CrossRef]
    [Google Scholar]
  • Wasilenko, S. T., Banadyga, L., Bond, D. & Barry, M. ( 2005; ). The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol 79, 14031–14043.[CrossRef]
    [Google Scholar]
http://sgm.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82772-0
Loading

Supplementary Data

 Data loading....

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82772-0
2007-06-01
2019-02-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/6/1656.html?itemId=/content/journal/jgv/10.1099/vir.0.82772-0&mimeType=html&fmt=ahah

Author and Article Information

 Figure data loading....

Footnotes:

Validated antibodies in this article

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error